October 23, 20255 min reAd

The Science of Cellular Aging: How NAD+, Growth Hormone, and Methylation Work Together

Longevity
Article

Introduction: Aging Isn’t One Problem — It’s Three Running in Parallel

If you read most longevity articles, they focuson a single mechanism: take this one supplement, boost this one molecule, fixthis one pathway. But aging doesn’t work that way. It’s a convergence ofmultiple interconnected declines happening simultaneously — and addressing onlyone while ignoring the others produces limited results.

Three of the most well-documented andconsequential age-related declines are NAD+ depletion, growth hormonereduction, and methylation dysfunction. Individually, each drives significantaspects of aging. Together, they create a self-reinforcing cycle thataccelerates the entire process.

Luvo’s longevity program is specificallydesigned to address all three — and the science explains why this integratedapproach matters.

Pillar One: NAD+ and Cellular Energy

NAD+ sits at the center of cellular energymetabolism. As the essential coenzyme for mitochondrial ATP production, NAD+determines how efficiently your cells convert nutrients into usable energy.When NAD+ declines, mitochondria become dysfunctional — they produce less energyand more reactive oxygen species (free radicals), creating oxidative stressthat damages cellular components.

But NAD+’s role extends beyond energy. It’sthe required substrate for sirtuins, the family of proteins that regulate DNArepair, inflammation, and metabolic homeostasis. It’s consumed by PARP enzymesduring DNA repair. And it participates in over 500 enzymatic reactions thatmaintain cellular function.

The decline of NAD+ with age is a masterswitch that affects virtually every other cellular process. This is why NAD+therapy — whether through Luvo’s NAD+ injection, oral drops, or nasal spray —forms one pillar of the longevity program.

Pillar Two: Growth Hormone and Tissue Maintenance

Growth hormone (GH) and its downstreammediator, IGF-1, are the body’s primary signals for tissue repair,regeneration, and maintenance. GH stimulates protein synthesis in muscles,collagen production in skin and connective tissue, bone mineralization, andimmune cell production.

The decline in GH production with age — termedsomatopause — directly contributes to muscle wasting (sarcopenia), increasedvisceral fat, reduced bone density, slower wound healing, and declining immunecompetence. These aren’t cosmetic issues; they’re functional declines thatpredict frailty, falls, metabolic disease, and reduced quality of life.

Sermorelin addresses somatopause by restoringthe pituitary’s natural GH output. But here’s the critical connection: growthhormone’s tissue-building effects require adequate cellular energy. Withoutsufficient NAD+ to power the metabolic machinery, the cells receiving GH’srepair signals may not have the energy to execute them. This is why Sermorelinand NAD+ therapy work better together than either does alone.

Pillar Three: Methylation and Epigenetic Maintenance

Methylation is a biochemical process where amethyl group (CH3) is transferred from one molecule to another. This seeminglysimple reaction is involved in DNA repair and gene expression regulation,neurotransmitter synthesis (serotonin, dopamine, melatonin), detoxification ofenvironmental toxins and metabolic waste, immune system regulation, andhistamine metabolism.

The methylation cycle requires adequate levelsof B12, folate, methionine, and choline — exactly the components in Luvo’sB12/MIC injection. When methylation declines with age or due to nutrientinsufficiency, the consequences cascade across multiple systems.

Perhaps most importantly, methylation is themechanism behind epigenetic regulation — the system that determines which genesare turned on or off. Disrupted methylation leads to aberrant gene expressionpatterns that are increasingly recognized as a hallmark of biological aging.Researchers now use DNA methylation patterns as “epigenetic clocks” to measurebiological age.

The Convergence: Why Integrated Treatment Outperforms Single Therapies

These three systems don’t operate inisolation. They’re deeply interconnected.

NAD+ fuels the sirtuins that regulateepigenetic patterns (methylation). Growth hormone stimulates tissue repair thatrequires NAD+-powered energy. Methylation recycles the precursors needed forboth NAD+ biosynthesis and growth hormone signaling. B12 and methionine supportthe salvage pathways that regenerate NAD+ from its metabolites.

When you address only one pillar, the othersbecome rate-limiting. Boosting NAD+ without supporting growth hormone leavesthe repair signals inadequate. Stimulating growth hormone without supportingcellular energy leaves cells unable to respond. Supporting methylation withoutadequate NAD+ limits the epigenetic maintenance that methylation is supposed toprovide.

This is the fundamental insight behind Luvo’smulti-therapy longevity program. Sermorelin, NAD+ therapy, and Vitamin B12/MICaren’t three random treatments bundled together — they’re three interventionstargeting the three pillars of cellular aging in a way that creates genuinesynergy.

Explore Luvo’s complete longevity program tounderstand how these therapies work together for your health.

starting AT
$
25
per week · billed annually

Get access to Luvo's longevity program

  • Comprehensive clinical evaluation
  • Personalized, clinician-guided treatment plan
  • Prescription options when clinically appropriate.
  • Ongoing provider messaging
  • Dose adjustments based on clinical response
  • Pharmacy fulfillment and delivery
Get started
No commitment until clinician review
Cancel anytime